Member Info for hubster1

Goldman, like any other broker, is serving their own interest with the ITM forecast. This is the same broker who is involved in the absurdly high SpaceX valuation..........which I am avoiding like the plague.

Https://cannabis-europa.com/speakers/avihu-tamir/

Personally I think the medical market is far more interesting for Kromek than defence........I'm far more positive about it being used in scanners for imaging than anything military.

It wouldn't have been accurate even a few days ago.

I will leave your ramping forum - good luck to you all, but don't lose sight of the facts. This company reminds me of Extract Resources and Helium one.

"Hubster what are you talking about ?

Are you a Geologist now and your best mate a Petroleum Engineer ?

I suggest you listen to it again and very carefully as it tells you an awful lot."

I'm not aware of any new information in that video that wasn't already published? Felt as though they were pitching to an audience with no prior knowledge of the exploration industry, rather than providing a useful market update.

Interesting too that they don't actually know the current location of their leased vessel (Gyre), which is in safe harbour (anchored) and not out working as claimed.

Having just watched the video, I would be exceptionally cautious with this company. The presentation felt like something any one of us could knock up if asked to present progress. Very surprised they chose to release it.

For me the most interesting thing to happen recently is that Avihu Tamir has broken his LinkedIn radio silence.........last week he was promoting a General Manager position for Telehealth...........no doubt rising from the ashes, funded by shareholders.

"About the job

Role: General Manager, UK Telehealth Clinic, Medical Cannabis (CBPMs)

Location: UK (remote)

Compensation: £90,000 base + up to £30,000 bonus (OTE £120,000)

The opportunity

We are looking for a commercially sharp, credible healthcare leader to take full ownership of a CQC-registered telehealth clinic at a pivotal moment in its journey. This is a rare chance to put your stamp on a healthcare business at exactly the right moment. You will have the backing of an experienced global group, the autonomy to lead locally, and the mandate to build something credible, compliant, and profitable from the ground up.

The clinic has recently been acquired by a highly successful international telehealth group and now needs a Country General Manager who can stabilise, rebuild, and grow the operation with confidence, pace, and rigour. If you thrive in regulated environments and want the authority to shape outcomes rather than manage symptoms, this role is for you.

Why this role is different

True GM accountability: full P&L ownership, not just operational oversight

High-impact turnaround: you will lead the reset and set the future direction

Commercial freedom with guardrails: build growth that works within regulation

Board-level influence: UK lead and member of the global executive team

Massive market opportunity: one of the UK’s fastest-evolving therapeutic areas

Remote-first with real autonomy and trust

What you’ll be trusted to do

You will be the person who brings clarity and momentum. In your first year, you will:

Stabilise the business post-acquisition and restore confidence with regulators, clinicians, suppliers, and patients

Shape a compliant operating model that is ready to scale

Take full ownership of financial performance and drive the business to sustainable profitability

Build a commercially disciplined growth engine with controlled patient acquisition costs

Lead and align clinical and non-clinical teams around clear goals and accountability

This is a hands-on leadership role. You will be close to the detail when needed, and firmly focused on outcomes at all times.

Who this will suit

You are likely already operating at senior level in healthcare, telehealth, or another tightly regulated environment. Experience in medical cannabis or like sectors is a strong advantage, but not essential.

You bring:

Proven experience running or turning around a regulated healthcare business

Comfort owning a P&L and making commercially tough decisions

The credibility to work confidently with clinicians, regulators, Boards, and investors

A calm, decisive leadership style when the pressure is on

A patient-first mindset paired with sharp commerci

What an odd RNS - including a gmail account ! Not exactly professional, and very telling if the director doesn't even use a corporate email.

sharonmalka1972@gmail.com

Haven’t looked at this page for a while……..your best bet is to monitor companies house for the various dubious notifications. I saw this in October……..what’s most telling is that the letter is dated April.

PRIVATE &CONFIDENTIAL The Directors

Kanabo Group Pic

137-139 Brent Street

London

NW4 4DJ

United Kingdom

Date 7 April 2025

Our Ref SAVK/LC172539

Dear Sirs

Kanabo Group PIc

Company registered number 10485105

Statement of Reasons

An independent member of mha

bakertilly INTERNATIONAL

In connection with our resignation as Auditor of the above-named company and ni accordance with Section 519 of the Companies Act 2006 we state that the reason for our resignation is transfer of audit services from Macintyre Hudson LLP to MHA Audit Services LLP

We confirm that none of the reasons for us ceasing to hold office and no matters connected with our ceasing to hold office need to be brought to the attention of members or creditors of the company

Yours faithfully MHA

MHA

Really I think it coming out of suspension is incredibly unlikely. Avihu Tamir has gone radio silent for months on all forms of communication, including Linkedin where he used to comment on other people's posts etc. He's become a ghost - Treat IT continues to get one of two very bad reviews every so often, and lists affiliated pharmacies on their website who've never heard of them. Companies house has the shambles of irregular reporting. I'm sure it suits Kanabo to have the suspension - completely off grid.

I would doubt it, as the shares would technically still exist unless the company went into administration. You'd of course also need to have held the shares outside of an ISA for that to be even a possibility.

In response to your question :

"How would this platform be financially beneficial to Kanabo shareholders and how would the revenue income be managed"

I would say there's no chance of there being an ongoing benefit or revenue stream for Kanabo. The fact that they responded directly with :

'Thank you for reaching out.

Please note that thegpservice.co.uk website and primary care brand is no longer affiliated with Kanabo Group PLC.'

..........it's clear that shareholders cannot expect any ongoing benefit.

It's suspended as they've failed to submit year end accounts..........for obvious reasons I'd suggest.

Another 3 months and it'll be struck off altogether.

Https://book.thegpservice.co.uk/about-us/

In today's news, the GP Service has changed their website yet again.............stating :

2025 (Current)

Acquired by Novamedica Limited

Pivoted to a global healthcare marketplace connecting UK and International providers.

So it went from Novomedica acquiring them, to the Sri Lankan individual, and back again to Novomedica in just a few days.

Must be a confusing place to work.

If you read this submission on companies house :

21 Jul 2025 Amended group of companies' accounts made up to 31 December 2023

I would suggest there is no intention to ever release meaningful revenue information from the GP Service. They have explicitly stated that the GP Service is exempt from audit in that submission.

I would also say there is evidence to the contrary of your statement ' there is no direct evidence that the company have an intent to defraud its investors'

I called 3 of the pharmacies (ones I'm familiar with) listed as collaborating on https://treat-it.clinic/clinics/ and they'd never heard of it. I would consider that deliberate and damaging for a company which is bound by medical standards. I would encourage you to call any pharmacy listed in your local area and would be very interested to hear your experience.

Agree with the principles, but having been a holder in JQW plc previously (fortunately sold before they were suspended) I don't hold any faith in enforcement of the rules. Time and time again financial impropriety goes unchecked.

I suspect only a majority shareholding approval would be needed, and I suspect they would have that majority with all the insider interests. Doubt any disposals would ever need to come to a retail investor vote.

I don't have a template I'm afraid, in the sense that the emails I've sent are personal to my case / findings; I think a personal email would be far more effective in any case.

Thus far I've emailed :

investgations@ft.com

dan.mccrum@ft.com

info@tcij.org (centre for investigative journalism)

If you're pondering what to write, I've highlighted some of the following :

- The steady resignation of directors leading up to the suspension

- The transfer of shares by Ian Mattioli last year, which would have enabled them to be sold without disclosing a director deal

- The peculiar recent filing by Kanabo plc on companies house, containing amended 2023 accounts (in which they declare they forgot to submit paperwork which excludes The GP Service from statutory audit)

- The posting on the GP Service website that it had been acquired by Novomedica (company# 16437130) whose director is Suleman SACRANIE. The same man who led Kanabo to acquire it for £14M in 2022

- The change in posting, removing that statement, and replacing it with 'Acquired by Levein Technologies Limited' whose director is a Sri Lankan individual. The company filings show no significant assets to make such an acquisition.

- No RNS relating the GP Service

- The appointment of Sharon Malka as a director of the GP Service during a period of suspension; Again no RNS

- The GP Service themselves sending me an email to say they no longer have an association with Kanabo

- No update on the Kanabo website, which still shows the GP Service association and a link to it

- The Treat IT website references pharmacies which have no knowledge of their service

- Kanabo products have been unavailable for months at any sales outlet

- Avihu Tamir has stopped posting on any forum, including Linkedin, and there is no response from his email addresses

- No response from my emails to their NOMAD Peterhouse Capital (and I have their director's email, who has responded once in the past)

- No response from my email to their auditor MHA. They were in the news this year for audit failures, which doesn't inspire confidence

https://www.cityam.com/mha-watchdog-opens-probe-over-audits-of-folded-construction-firm/

I could go on - The thing that will get this traction is personal impact stories, so I'd encourage you to share your situation with as many journalists as you can.

I tell a lie - Southwold is still listed.

I encourage you to call any pharmacies in your area and verify.

We need some traction from an investigative journalist on this one.

I've emailed dan.mccrum@ft.com

Not had a reply, but I'm going to keep emailing. I would suggest others do the same, and to as many journalists as you can find.

My gut feel is that Kanabo knowingly overpaid massively for The GP Service, only to offload it back at a fraction of the cost. Shareholder monies will have evaporated, and with it being offloaded under suspension I imagine the audit trail goes with it.

The directors involved here all appear known to each other.

I suspect the UK directors resigned when they suspected something was wrong, as they didn't want to be associated with it.

What did Kanabo ever actually produce?

In reality we've seen some cheap vapes that could have been produced in China.

Even more interesting is their fraudulent listings here :

https://treat-it.clinic/clinics/

I am very familiar with Southwold, and know the pharmacy well. Last week their pharmacy was listed as a referral centre for Treat IT. This week they've been removed. I spoke with the pharmacy and they've never heard of Treat IT (as I suspected).

I believe they are just rotating around pharmacies on that site, pretending they have a connection..........when in reality they have none.